Persisting facial nerve palsy or trigeminal neuralgia - red flags for perineural spread of head and neck cutaneous squamous cell carcinoma (HNcSCC).
head and neck cancer
perineural spread
squamous cell carcinoma
Journal
ANZ journal of surgery
ISSN: 1445-2197
Titre abrégé: ANZ J Surg
Pays: Australia
ID NLM: 101086634
Informations de publication
Date de publication:
10 2023
10 2023
Historique:
revised:
11
07
2023
received:
09
01
2023
accepted:
12
07
2023
medline:
23
10
2023
pubmed:
24
7
2023
entrez:
24
7
2023
Statut:
ppublish
Résumé
Perineural spread (PNS) of head and neck cutaneous squamous cell carcinoma (HNcSCC) is a unique diagnostic challenge, presenting with insidious trigeminal (CN V) or facial nerve (CN VII) neuropathies without clinically discernible primary masses. These patients are often sub-optimally investigated and misdiagnosed as Bell's palsy or trigeminal neuralgia. This case series highlights the red flags in history and pitfalls that lead to delays to diagnosis and treatment. A retrospective case series of 19 consecutive patients with complete clinical histories with HNcSCC PNS without an obvious cutaneous primary lesion at time of presentation to a quaternary head and neck centre in Australia were identified and included for analysis. Fifteen had CN VII PNS, 17 had CN V PNS, and 13 had both. The overall median symptom-to-diagnosis time was 12-months (IQR-15 months). Eight patients had CN VII PNS and described progressive segmental facial nerve palsy with a median symptom-to-diagnosis time of 9-months (IQR-11.75 months). Eleven patients had primary CN V PNS and described well localized parathesia, formication or neuralgia with a median symptom-to-diagnosis time of 19-months (IQR 27.5 months). PNS is often mistaken for benign cranial nerve dysfunction with delays in diagnosis worsening prognosis. Red flags such as progressive CN VII palsy or persistent CN V paraesthesia, numbness, formication or pain, particularly in the presence of immuno-compromise and/or a history of facial actinopathy should raise suspicion for PNS. Gadolinium-enhanced MR Neurography should be obtained expediently in patients with persistent/progressive CN V/CN VII palsies in patients with red flags, with low threshold for referral to a Head and Neck Surgeon.
Sections du résumé
BACKGROUND
Perineural spread (PNS) of head and neck cutaneous squamous cell carcinoma (HNcSCC) is a unique diagnostic challenge, presenting with insidious trigeminal (CN V) or facial nerve (CN VII) neuropathies without clinically discernible primary masses. These patients are often sub-optimally investigated and misdiagnosed as Bell's palsy or trigeminal neuralgia. This case series highlights the red flags in history and pitfalls that lead to delays to diagnosis and treatment.
METHODS
A retrospective case series of 19 consecutive patients with complete clinical histories with HNcSCC PNS without an obvious cutaneous primary lesion at time of presentation to a quaternary head and neck centre in Australia were identified and included for analysis.
RESULTS
Fifteen had CN VII PNS, 17 had CN V PNS, and 13 had both. The overall median symptom-to-diagnosis time was 12-months (IQR-15 months). Eight patients had CN VII PNS and described progressive segmental facial nerve palsy with a median symptom-to-diagnosis time of 9-months (IQR-11.75 months). Eleven patients had primary CN V PNS and described well localized parathesia, formication or neuralgia with a median symptom-to-diagnosis time of 19-months (IQR 27.5 months).
CONCLUSION
PNS is often mistaken for benign cranial nerve dysfunction with delays in diagnosis worsening prognosis. Red flags such as progressive CN VII palsy or persistent CN V paraesthesia, numbness, formication or pain, particularly in the presence of immuno-compromise and/or a history of facial actinopathy should raise suspicion for PNS. Gadolinium-enhanced MR Neurography should be obtained expediently in patients with persistent/progressive CN V/CN VII palsies in patients with red flags, with low threshold for referral to a Head and Neck Surgeon.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2394-2401Subventions
Organisme : Cancer Institute NSW
ID : CINSW2020/2081
Organisme : Lang Walker Family Foundation
Organisme : National Health and Medical Research Council
Organisme : Sydney Local Health District
Informations de copyright
© 2023 Royal Australasian College of Surgeons.
Références
Yung AE, Crouch G, Varey AHR et al. Benchmarking survival outcomes following surgical management of pT3 and pT4 cutaneous squamous cell carcinoma of the head and neck. Ann. Surg. Oncol. 2022; 29: 5141-5142.
Karia PS, Morgan FC, Ruiz ES, Schmults CD. Clinical and incidental perineural invasion of cutaneous squamous cell carcinoma: a systematic review and pooled analysis of outcomes data. JAMA Dermatol. 2017; 153: 781-788.
Carter JB, Johnson MM, Chua TL, Karia PS, Schmults CD. Outcomes of primary cutaneous squamous cell carcinoma with perineural invasion: an 11-year cohort study. JAMA Dermatol. 2013; 149: 35-41.
Phung D, Ahmadi N, Gupta R et al. Survival outcomes of perineural spread in head and neck cutaneous squamous cell carcinoma. ANZ J. Surg. 2022; 92: 2299-2304.
Warren TA, Nagle CM, Bowman J, Panizza BJ. The natural history and treatment outcomes of perineural spread of malignancy within the head and neck. J. Neurol. Surg. B Skull Base. 2016; 77: 107-112.
Paes FM, Singer AD, Checkver AN, Palmquist RA, Vega GDL, Sidani C. Perineural spread in head and neck malignancies: clinical significance and evaluation with 18F-FDG PET/CT. Radiographics 2013; 33: 1717-1736.
Williams LS, Mancuso AA, Mendenhall WM. Perineural spread of cutaneous squamous and basal cell carcinoma: CT and MR detection and its impact on patient management and prognosis. Int. J. Radiat. Oncol. Biol. Phys. 2001; 49: 1061-1069.
Nightingale J, Gandhi M, Helena J et al. Immunotherapy for the treatment of perineural spread in cutaneous head and neck squamous cell carcinoma: time to rethink treatment paradigms. Head Neck 2022; 44: 1099-1105.
Warren TA, Whiteman DC, Porceddu SV, Panizza BJ. Insight into the epidemiology of cutaneous squamous cell carcinoma with perineural spread. Head Neck 2016; 38: 1416-1420.
Mendenhall WM, Parsons JT, Mendenhall NP et al. Carcinoma of the skin of the head and neck with perineural invasion. Head Neck 1989; 11: 301-308.
Warren TA, Panizza B, Porceddu SV et al. Outcomes after surgery and postoperative radiotherapy for perineural spread of head and neck cutaneous squamous cell carcinoma. Head Neck 2016; 38: 824-831.
Parker GD, Harnsberger HR. Clinical-radiologic issues in perineural tumor spread of malignant diseases of the extracranial head and neck. Radiographics 1991; 11: 383-399.
Gandhi M, Sommerville J. The imaging of large nerve perineural spread. J. Neurol. Surg. B Skull Base. 2016; 77: 113-123.
Baulch J, Gandhi M, Sommerville J, Panizza B. 3T MRI evaluation of large nerve perineural spread of head and neck cancers. J. Med. Imaging Radiat. Oncol. 2015; 59: 578-585.
Brown IS. Pathology of perineural spread. J. Neurol. Surg. B Skull Base. 2016; 77: 124-130.
Krafft RM. Trigeminal neuralgia. Am. Fam. Physician 2008; 77: 1291-1296.
Timothy JE, Glen RC, Peter GEK, Tessa H, Arun VK. Bell's palsy: aetiology, clinical features and multidisciplinary care. J. Neurol. Neurosurg. Psychiatry 2015; 86: 1356.
Schachtel MJC, Gandhi M, Bowman JJ, Porceddu SV, Panizza BJ. Facial nerve perineural spread from cutaneous squamous cell carcinoma of the head and neck: a single institution analysis of epidemiology, treatment, survival outcomes, and prognostic factors. Head Neck 2022; 44: 1223-1236.